Jefferies Makes Another Bullish Healthcare Call

MNOV is another name from the healthcare sector to watch today

Mar 29, 2018 at 10:29 AM
facebook twitter linkedin


Brokerage firm Jefferies has been weighing in on a number of healthcare stocks this week, predicting big upside for AnaptysBio (ANAB) and Arrowhead Pharmaceuticals (ARWR). This morning, the firm turned its attention to Miragen Therapeutics Inc (NASDAQ:MGEN), initiating coverage with a "buy" rating and $14 price target -- well above the shares' Wednesday settlement at $6.82. The covering analyst suggested data from upcoming drug trials could push MGEN stock higher from its seemingly cheap valuation. At last check, the shares are up 3.1% to trade at $7.03.

Interestingly, this bullish attention is nothing new for the drugmaker. In fact, all six brokerage firms in coverage have "strong buy" recommendations, and the average 12-month price target is a very elevated $17.93 -- territory not charted since last March.

Looking back, the shares haven't done much to earn this bullish bias. They're down 40.8% over the past year, and a breakout attempt back in December and January was quickly thwarted by the 200-day moving average.

Taking a quick look at another big healthcare mover this morning, MediciNova, Inc. (NASDAQ:MNOV) is trading down 12% at $10.51, following disappointing mid-stage trial results for the company's methamphetamine dependence treatment -- its lead drug candidate. MNOV has fallen below the 50-day moving average for the first time since the start of the year, but remains up more than 62% year-to-date.

Many people are betting against the drugmaker, though. Short interest increased 16.5% in the last two reporting periods, and now accounts for more than 10% of the equity's float. Going by average daily volumes, it'd take short sellers more than two weeks to buy back their positions. The shares are short-sale restricted today, however.

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners